I affirm the mission of the ICMS.

1. To maximize patient outcomes by producing guidelines for the use of autologous adult stem cells (A-ASC) in medicine.

2. To provide standards for minimal culture expansion of A-ASC’s and their re-implantation.

3. To establish that when A-ASCs are minimally culture expanded, are not biologic drugs but rather human tissue.

4. To assert that the minimal culture expansion of A-ASCs is a medical procedure.

5. To educate physicians concerning minimal cell culture expansion techniques, cell transplant procedures, and cell based medical care, and set standards for the safe implementation of such techniques consistent with best clinical practices and/or evidence based medicine.

6. To provide public education regarding therapeutic applications of A-ASC therapy.

7. To establish a voluntary national registry of minimally expanded autologous A-ASC therapy results, including surveillance and tracking of complications.

8. To periodically describe the results of the national registry in the peer-reviewed and relevant literature.

9. To cooperate with any governmental or institutional oversight bodies for the release of information from the registry.